Impact of Remote Blood Pressure Monitoring Device Connectivity on Engagement Among Pregnant Individuals Enrolled in the Delfina Care Platform: Observational Study.

Autor: Charifson M; Delfina Care Inc, San Francisco, CA, United States.; Department of Population Health, New York University, New York, NY, United States., Wen T; Delfina Care Inc, San Francisco, CA, United States.; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA, United States., Zell B; Delfina Care Inc, San Francisco, CA, United States., Vaidya P; Delfina Care Inc, San Francisco, CA, United States., Rios CI; Delfina Care Inc, San Francisco, CA, United States.; Center for Women's Health, Richmond, TX, United States., Fagbohun CF; Delfina Care Inc, San Francisco, CA, United States.; Center for Women's Health, Richmond, TX, United States., Fulcher I; Delfina Care Inc, San Francisco, CA, United States.

Publikováno v: JMIR mHealth and uHealth [JMIR Mhealth Uhealth] 2024 Jul 12; Vol. 12, pp. e55617. Date of Electronic Publication: 2024 Jul 12.

Radiation and Chemical Program Research for Multi-Utility and Repurposed Countermeasures: A US Department of Health and Human Services Agencies Perspective.

Autor: Rios CI; Radiation and Nuclear Countermeasures Program (RNCP), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), US Department of Health and Human Services (HHS), Washington, DC, USA., Garcia EE; Chemical Medical Countermeasures (MCM) Program, Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), Washington, DC, USA., Hogdahl TS 2nd; Burn/Blast MCM Program, Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), Washington, DC, USA., Homer MJ; Radiological/Nuclear MCM Program, Division of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures, Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), HHS, Washington, DC, USA., Iyer NV; Burn/Blast MCM Program, Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), Washington, DC, USA., Laney JW; Chemical Medical Countermeasures (MCM) Program, Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), Washington, DC, USA., Loelius SG; Radiological/Nuclear MCM Program, Division of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures, Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), HHS, Washington, DC, USA., Satyamitra MM; Radiation and Nuclear Countermeasures Program (RNCP), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), US Department of Health and Human Services (HHS), Washington, DC, USA., DiCarlo AL; Radiation and Nuclear Countermeasures Program (RNCP), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), US Department of Health and Human Services (HHS), Washington, DC, USA.

Publikováno v: Disaster medicine and public health preparedness [Disaster Med Public Health Prep] 2024 Feb 22; Vol. 18, pp. e35. Date of Electronic Publication: 2024 Feb 22.

Overlapping Science in Radiation and Sulfur Mustard Exposures of Skin and Lung: Consideration of Models, Mechanisms, Organ Systems, and Medical Countermeasures: Overlapping science in radiation and sulfur mustard injuries to lung and skin.

Autor: Satyamitra MM; Radiation and Nuclear Countermeasures Program (RNCP), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Maryland, USA., Andres DK; Chemical Medical Countermeasures Program, BARDA, Washington, DC, USA., Bergmann JN; Radiological/Nuclear Medical Countermeasures Program, Biomedical Advanced Research and Development Authority (BARDA), Washington, DC, USA., Hoffman CM; Radiological/Nuclear Medical Countermeasures Program, Biomedical Advanced Research and Development Authority (BARDA), Washington, DC, USA., Hogdahl T; Thermal Burn Medical Countermeasures Program, BARDA, Washington, DC, USA., Homer MJ; Radiological/Nuclear Medical Countermeasures Program, Biomedical Advanced Research and Development Authority (BARDA), Washington, DC, USA., Hu TC; Chemical Medical Countermeasures Program, BARDA, Washington, DC, USA., Rios CI; Radiation and Nuclear Countermeasures Program (RNCP), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Maryland, USA., Yeung DT; Chemical Countermeasures Research Program (CCRP), NIAID, NIH, Maryland, USA., DiCarlo AL; Radiation and Nuclear Countermeasures Program (RNCP), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Maryland, USA.

Publikováno v: Disaster medicine and public health preparedness [Disaster Med Public Health Prep] 2023 Oct 19; Vol. 17, pp. e552. Date of Electronic Publication: 2023 Oct 19.

The NIAID/RNCP Biodosimetry Program: An Overview.

Autor: Satyamitra MM; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA., Cassatt DR; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA., Molinar-Inglis O; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA., Rios CI; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA., Taliaferro LP; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA., Winters TA; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA., DiCarlo AL; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA.

Publikováno v: Cytogenetic and genome research [Cytogenet Genome Res] 2023; Vol. 163 (3-4), pp. 89-102. Date of Electronic Publication: 2023 Sep 22.

Commentary on Animal Care in Radiation Medical Countermeasures Studies.

Autor: Satyamitra MM; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Taliaferro LP; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Rios CI; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland.

Publikováno v: Radiation research [Radiat Res] 2022 Nov 01; Vol. 198 (5), pp. 508-513.